sFc (single chain Fc) platform

The present invention relates to a therapeutic fusion protein comprising an Fc fragment of immunoglobulin G and a biologically active molecule, wherein the Fc fragment is a single chain. Method for designing corresponding fusion protein is also provided.

*This invention has been granted in United States, Taiwan, China, Japan, India, Hong Kong, Malaysia, Singapore, Australia, Europe and Canada.